Metagenomic Analysis of the Intestinal Microbiota of premature infants undergoing treatment with Colostrotherapy treated by the Unified Health System (SUS): Intervention Study

Jessica Santos Passos Costa0 个研究点开始时间: 2020年3月25日最近更新: 2023年5月29日

适应症

试验速览

暂无简介。

•The inclusion criteria for the control group (from HEC) will be: premature newborns
•admitted to Neonatal Units, birth weight 1,500g, 32 weeks gestational age, They must be on a zero diet orally and enteral or using total parenteral nutrition (NTP), and / or enteral administration of infant formula and clinically stable, with normal parameters. In addition, to collect the fecal sample, the newborn will be included if the first evacuation was made at the NICU. The mothers of infants, both for the group of intervention, as well as for the control group, will be selected according to the eligibility criteria of your children's entry into the study

•Among the exclusion criteria: mother's, maternal history of substance use psychoactive drugs, drugs, alcohol, presence of
•psychological disorder, multiple pregnancy from triplets and children of mothers contraindicated for breastfeeding retroviruses and cytomegalovirus). RN: use of vasopressor medication bigger then 10mcg / Kg / min, requirement for immediate surgical intervention, syndromes and / or congenital malformations, neonatal morbidities such as the incidence of patent ductus arteriosus (PDA), sepsis or necrotizing enterocolitis (NEC), The newborn who eliminates meconium in the Obstetric Center (CO).

发起方

Jessica Santos Passos Costa